Michael Didocha Joins Telix as Chief Financial Officer, Americas

31 August 2021 – Corporate Spotlight | Michael Didocha appointed Chief Financial Officer, Telix Americas

Telix is delighted to announce the appointment of Michael Didocha as Chief Financial Officer for the Americas region.

Michael joins with approximately 20 years’ experience in life science manufacturing and commercialisation. Prior to joining Telix, Michael worked at Roche where he served for 16 years across various executive positions, including as Director of Finance from 2017.

Mr. Didocha holds a Master of Business Administration in Finance and Accounting from Indiana University Kelley School of Business, and a Bachelor of Science in Mechanical Engineering from Georgia Institute of Technology.

On joining Telix, Michael stated, “Any cancer diagnosis today means that a patient is facing painful procedures and uncertain outcomes.  The promise of personalised radionuclide therapies to treat cancer presents an exciting possibility to make a real difference in people’s lives.  It is clear that Telix has both the talent and mindset to make these treatments a reality.  It’s truly an honor to be joining this team, and I am very excited to be a part of this journey.”

Dr. Bernard Lambert, President, Telix Americas added, With broad experience in strategic business planning and financial accounting across life sciences and medical devices, Michael is a strong fit to lead our financial operations in the Americas region. He joins at a pivotal moment in the Company’s evolution, as we prepare for the launch of illuccix®, with the hope that brings for US men suffering with prostate cancer.”

We welcome Michael to the Telix team, as we work to deliver on our mission to help patients with cancer live longer, better quality lives.

To read the full press release please click here.

To return to our home page please click here.